Eva Horvath

835 citations
10 papers · 654 indexed · h-index 10
Topics
Pituitary Gland Disorders and Treatments (8 papers)Growth Hormone and Insulin-like Growth Factors (3 papers)Cell death mechanisms and regulation (2 papers)
Partner nations
CanadaUnited StatesJapan

In The Last Decade

Eva Horvath

10 papers receiving 637 citations

Peers

Eva Horvath
Comparison fields: 5 of 52
  • Endocrinology, Diabetes and Metabolism 564
  • Genetics 270
  • Surgery 187
  • Epidemiology 179
  • Molecular Biology 120
Replace Ricardo V. Lloyd with:
Ricardo V. Lloyd United States
Eivind Carlsen United Kingdom
León Darío Ortiz Colombia
Mirela Diana Ilie France
B. Scheithauer United States
Donato Iacovazzo United Kingdom
Takao Kuroki Japan
H A Bikkal United States
Sonia Cheng Canada
Emilia Ballarè Italy
Eva Horvath relative to Ricardo V. Lloyd United States Ricardo V. Lloyd's profile →
Citations per field
00.5×3.3×
Ricardo V. Lloyd · 1×
Citations per year

Countries citing papers authored by Eva Horvath

Since Specialization
Citations

This map shows the geographic impact of Eva Horvath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Horvath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Horvath more than expected).

Fields of papers citing papers by Eva Horvath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Horvath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Horvath. The network helps show where Eva Horvath may publish in the future.

Co-authorship network of co-authors of Eva Horvath

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Horvath. A scholar is included among the top collaborators of Eva Horvath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Horvath. Eva Horvath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 19
2 105
3 30
4 58
5 48
6 282
7 17
8 30
9 23
10 42

About Eva Horvath

Eva Horvath is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Immunology, having authored 10 papers that have together received 654 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (8 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (564 citations), Genetics (270 citations) and Epidemiology (179 citations). Eva Horvath has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include B. W. Scheithauer, Ricardo V. Lloyd, Kálmán Kovács, Dudley H. Davis, William F. Young, Peter Pernicone, Barton L. Guthrie, Thomas J. Sebo, Kalman Kovacs and Sergio Vidal. Their work appears in journals such as Cancer, Journal of neurosurgery and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026